Access the full text.
Sign up today, get DeepDyve free for 14 days.
LK Metrock (2017)
Respiratory Difficulties in Children With Underlying Asthma During Immunotherapy for High-risk Neuroblastoma.Journal of Pediatric Hematology/Oncology, 39
Reactions 1680, p243 - 2 Dec 2017 by 2 episodes of pneumonia. The girl was treated with salbutamol [albuterol] and antibiotics. She also underwent autologous stem cell rescue (ASCR) using thiotepa, cyclophosphamide, carboplatin, etoposide and melphalan. Various toxicities: 3 case reports However, the ASCR was complicated by cough, wheezing and In a case series, three patients (2 boys and 1 girl) aged hypoxia. Her respiratory distress worsened, following which, between 32 months 4 years were described, who developed she required transfer to the ICU. She then received treatment various toxicities following the therapy with various drugs [ not with methylprednisolone. Consequently, her hypoxia all dosages and times to reactions onsets stated; routes not resolved. She was then discharged on daily inhaled steroids stated ]. Patient 1: The 32-month-old boy, who had asthma, and salbutamol as needed. During her second ASCR, she was was intermittently treated with salbutamol [albuterol] and placed on prophylactic steroids 2 days before admission. She budesonide. He was eventually diagnosed with again required transfer to the ICU on day 9 after the ASCR due neuroblastoma. He received 6 cycles of chemotherapy with to respiratory distress. Thereafter, she received cyclophosphamide, topotecan, cisplatin, etoposide, vincristine methylprednisolone treatment. She
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
Access the full text.
Sign up today, get DeepDyve free for 14 days.